Myelodysplastic%20Syndromes
Showing 1 - 25 of 3,174
MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)
Recruiting
- Myelodysplastic Syndromes
- IV Decitabine
- +2 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,Zhejiang University School of Medi
Oct 23, 2023
MDS Trial in Houston (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2023
MDS, Ferroptosis Trial in Pessac (Biological sampling)
Not yet recruiting
- Myelodysplastic Syndromes
- Ferroptosis
- Biological sampling
-
Pessac, France
- +2 more
Jun 19, 2023
MDS Trial (Decitabine/Cedazuridine, Magrolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- (no location specified)
Apr 18, 2023
Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome
Recruiting
- Myelodysplastic Syndromes
- Blood test
-
Jerusalem, IsraelShaare Zedek Medical Center
Nov 27, 2023
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)
Not yet recruiting
- Myelodysplastic Syndromes
- decitabine and cedazuridine
- BMS-986253
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Biospecimen Acquisition for Myelodysplastic Syndromes
Recruiting
- Myelodysplastic Syndromes
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)
Not yet recruiting
- AML/MDS
- +2 more
- Danvatirsen
- Danvatirsen + Venetoclax
- (no location specified)
Aug 14, 2023
Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Rochester, Minnesota
- +1 more
Feb 15, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Anemia Trial (Luspatercept)
Not yet recruiting
- Anemia
- Luspatercept
- (no location specified)
May 26, 2023
Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +3 more
Nov 21, 2023
Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome
Not yet recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 5, 2023
Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)
Not yet recruiting
- Acute Myeloid Leukemia
- High-Risk and Very High-Risk Myelodysplastic Syndromes
- (no location specified)
Jul 25, 2023
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Sep 18, 2023
MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)
Recruiting
- Myelodysplastic Syndromes
- Unrelated Umbilical Cord Blood
- +3 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Oct 27, 2023
Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)
Not yet recruiting
- Myeloid Malignancy
- +4 more
- Telehealth Serious Illness Care Program
- Education Control
-
Rochester, New YorkUniversity of Rochester
May 24, 2023
High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)
Recruiting
- High Grade Myelodysplastic Syndromes
-
Aurora, ColoradoUniverstiy of Colorado Denver
Nov 17, 2022
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)
Recruiting
- Myelodysplastic Syndromes
- +5 more
- description of MDS pzatient cohort
-
Brest, FranceChu Brest
Oct 27, 2022